Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Larsen

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|May 1, 1995
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cellsS Lelièvre, Y Benchokroun, A K Larsen
Progress in Cell Cycle Research|January 1, 1996
The roles of DNA topoisomerase II during the cell cycleA K Larsen, A Skladanowski, K Bojanowski
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53C Gobert, A Skladanowski, A K Larsen
Biochemical Pharmacology|January 31, 1995
Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cellsY Benchokroun, J Couprie, A K Larsen
Pharmacology & Therapeutics|March 31, 2000
Resistance mechanisms associated with altered intracellular distribution of anticancer agentsA K Larsen, A E Escargueil, A Skladanowski
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1986
Comparative studies of heparin and heparin fragments: distribution and toxicity in the ratA K Larsen, P M Newberne, R Langer
Biochimica Et Biophysica Acta|July 21, 1994
Activation of protein kinase C during cell volume regulation in Ehrlich mouse ascites tumor cellsA K Larsen, B S Jensen, E K Hoffmann
Cancer Research|October 1, 1986
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cellsA K Larsen, J Paoletti, J Belehradek, et al.
Toxicology and Applied Pharmacology|June 30, 1987
In vivo exposure to four ellipticine derivatives with topoisomerase inhibitory activity results in chromosome clumping and sister chromatid exchange in murine bone marrow cellsG Renault, C Malvy, W Venegas, et al.
British Journal of Cancer|March 31, 1999
Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cellsM G Côme, A Skladanowski, A K Larsen, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|May 1, 1995
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cellsS Lelièvre, Y Benchokroun, A K Larsen
Progress in Cell Cycle Research|January 1, 1996
The roles of DNA topoisomerase II during the cell cycleA K Larsen, A Skladanowski, K Bojanowski
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53C Gobert, A Skladanowski, A K Larsen
Biochemical Pharmacology|January 31, 1995
Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cellsY Benchokroun, J Couprie, A K Larsen
Pharmacology & Therapeutics|March 31, 2000
Resistance mechanisms associated with altered intracellular distribution of anticancer agentsA K Larsen, A E Escargueil, A Skladanowski
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1986
Comparative studies of heparin and heparin fragments: distribution and toxicity in the ratA K Larsen, P M Newberne, R Langer
Biochimica Et Biophysica Acta|July 21, 1994
Activation of protein kinase C during cell volume regulation in Ehrlich mouse ascites tumor cellsA K Larsen, B S Jensen, E K Hoffmann
Cancer Research|October 1, 1986
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cellsA K Larsen, J Paoletti, J Belehradek, et al.
Toxicology and Applied Pharmacology|June 30, 1987
In vivo exposure to four ellipticine derivatives with topoisomerase inhibitory activity results in chromosome clumping and sister chromatid exchange in murine bone marrow cellsG Renault, C Malvy, W Venegas, et al.
British Journal of Cancer|March 31, 1999
Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cellsM G Côme, A Skladanowski, A K Larsen, et al.
Pageof 7